chr9-418193-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_203447.4(DOCK8):c.3826G>T(p.Val1276Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,614,202 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1276M) has been classified as Uncertain significance.
Frequency
Consequence
NM_203447.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DOCK8 | NM_203447.4 | c.3826G>T | p.Val1276Leu | missense_variant | 30/48 | ENST00000432829.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DOCK8 | ENST00000432829.7 | c.3826G>T | p.Val1276Leu | missense_variant | 30/48 | 1 | NM_203447.4 |
Frequencies
GnomAD3 genomes AF: 0.00108 AC: 165AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000318 AC: 80AN: 251474Hom.: 1 AF XY: 0.000250 AC XY: 34AN XY: 135912
GnomAD4 exome AF: 0.000112 AC: 163AN: 1461870Hom.: 2 Cov.: 33 AF XY: 0.000102 AC XY: 74AN XY: 727232
GnomAD4 genome AF: 0.00109 AC: 166AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000953 AC XY: 71AN XY: 74496
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 27, 2013 | Val1276Leu in exon30 of DOCK8: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (13/4406) of African American c hromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/E VS; dbSNP rs148796842). In addition, valine at position 1276 is poorly conserved in evolution, suggesting that a change may be tolerated. - |
Autosomal recessive hyper-IgE syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
DOCK8-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 12, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at